Healthy volunteers
Conditions
Interventions
Product Name: alcohol
Pharmaceutical Form: Oral solution
Sponsors
University of Iceland, Dept. Pharmacology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy, age 22-65 years. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: History of alcohol abuse, history of epileptic seizures, history of liver or kidney disease, chronic use of drugs with effects on the central nervous system or autonomic nervous system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To study the effects of alcohol on brain function (EEG) and the periferal nervous system (pupillary movements and galvanic skin conductance) and to correlate the effects with blood concentration of alcohol. ;Secondary Objective: No;Primary end point(s): Alpha and beta activity of the brain, velocity of pupillary dilatation after a light stimulus, galvanic skin conductance, heart rate. | — |
Countries
Iceland
Outcome results
None listed